Arrowhead Research Corp (ARWR): Arrowhead Pharmaceuticals shares are tra...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	791
Posts	51039
Boards Moderated	0
Alias Born	12/12/2004

crudeoil24

Re: None

Wednesday, 09/16/2020 11:32:47 AM

Wednesday, September 16, 2020 11:32:47 AM

Arrowhead Pharmaceuticals shares are trading higher after the company announced positive interim 24-week liver biopsy results in four subjects from AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the company's second-generation investigational RNA interference therapeutic.

ARWR

New York Yankees and Duke Basketball

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ARWR News

Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/19/2026 08:46:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:05:44 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:35:16 PM
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (US) • 05/12/2026 12:30:00 PM
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (Canada) • 05/12/2026 12:30:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:27:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:05:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:02:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 10:44:42 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/23/2026 08:44:48 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/22/2026 09:16:20 PM
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:05:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:00:06 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:49:43 PM
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • InvestorsHub NewsWire • 02/17/2026 02:00:00 PM
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2026 09:06:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:15 PM
Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 • PR Newswire (US) • 02/04/2026 11:15:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ARWR News

More ARWR News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ARWR News

Go Ad-Free